Biogenesis of lipoarabinomannan in mycobacteria Summary Phosphatidylinositol mannosides (PIM) and their multiglycosylated counterparts, lipomannan (LM) and lipoarabinomannan (LAM) are complex glycolipids and lipoglycans found in the envelopes of all mycobacterial species. They play various essential although poorly defined roles in mycobacterial physiology and are important immunomodulatory molecules in the course of tuberculosis and leprosy as well as key ligands promoting the entry of mycobacteria into phagocytic and non-phagocytic cells. Although much progress has been made over the last 20 years in elucidating the structures of these molecules, knowledge of the pathways leading to their biosynthesis, assembling and transport to the cell surface is still incomplete. The elucidation of these pathways, in addition to providing fundamental knowledge about the biochemistry of Mycobacterium tuberculosis, is expected to lead to the discovery of essential enzymes and transporters that could represent interesting targets for novel anti-TB drugs. The availability of recombinant mycobacterial strains accumulating biosynthetic precursors of these molecules would facilitate structure-function relationship studies and that of defined M. tuberculosis mutants deficient in various aspects of PIM, LM and LAM synthesis would allow a precise assessment of the contribution of these molecules to the immunopathogenesis of tuberculosis in vivo. Following an integrated approach in the form of bioinformatics, genetics and biochemistry, we propose to pursue our work on the identification and functional characterization of the enzymes involved in the elongation and assembling of PIM, LM and LAM and to further extend this work to the characterization of the transporters responsible for the translocation of biosynthetic intermediates and end products across the different layers of the cell envelope. Abbreviations: AM, arabinomannan;AcylT, acyltransferase;Araf, arabinofuranosyl;AraT, arabinosyltransferase;CZE, capillary zone electrophoresis;DOC, deoxycholate;ESI, electrospray ionization;GT, glycosyltransferase;LAM, lipoarabinomannan;LM, lipomannan;MALDI-TOF, Matrix-Assisted Laser desorption/ionization time of flight;Manp, mannopyranosyl;ManT, mannosyltransferase;MPI, mannosylated phosphatidylinositol;MS, mass spectrometry;myo-Ins, myo-inositol;ORF, open reading frame;investigator, phosphatidyl-myo-inositol;PIM, phosphatidyl-myo-inositol mannosides;TFA, trifluoroacetic acid;TLC, thin-layer chromatography. Nomenclature: PIM is used to describe the global family of phosphatidylinositol mannosides that carries one to four fatty acids (attached to the glycerol, inositol and/or mannose) and one to six mannose residues. In AcXPIMY, x refers to the number of acyl groups esterified to available hydroxyls on the mannose or myo-inositol residues, y refers to the number of mannose residues;e.g. Ac1PIM1 corresponds to the phosphatidylinositol mono-mannoside PIM1 carrying two acyl groups attached to the glycerol (the diacylglycerol substituent) and one acyl group esterified to the mannose residue.

Public Health Relevance

Dissection of the PIM, LM and LAM pathways in Mycobacterium tuberculosis will lead to the discovery of novel classes of essential enzymes and transporters that may represent attractive targets for therapeutic intervention. In addition, the mutants defective in some aspects of PIM, LM or LAM synthesis will help define the precise role of these molecules in immunopathogenesis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI064798-10
Application #
8665867
Study Section
Host Interactions with Bacterial Pathogens Study Section (HIBP)
Program Officer
Jacobs, Gail G
Project Start
2005-05-01
Project End
2015-05-31
Budget Start
2014-06-01
Budget End
2015-05-31
Support Year
10
Fiscal Year
2014
Total Cost
$353,057
Indirect Cost
$112,882
Name
Colorado State University-Fort Collins
Department
Microbiology/Immun/Virology
Type
Schools of Veterinary Medicine
DUNS #
785979618
City
Fort Collins
State
CO
Country
United States
Zip Code
80523
Daffé, Mamadou; Crick, Dean C; Jackson, Mary (2014) Genetics of Capsular Polysaccharides and Cell Envelope (Glyco)lipids. Microbiol Spectr 2:
Angala, Shiva Kumar; Belardinelli, Juan Manuel; Huc-Claustre, Emilie et al. (2014) The cell envelope glycoconjugates of Mycobacterium tuberculosis. Crit Rev Biochem Mol Biol 49:361-99
Kaur, Devinder; Angala, Shiva K; Wu, Sz-Wei et al. (2014) A single arabinan chain is attached to the phosphatidylinositol mannosyl core of the major immunomodulatory mycobacterial cell envelope glycoconjugate, lipoarabinomannan. J Biol Chem 289:30249-56
Shukla, Supriya; Richardson, Edward T; Athman, Jaffre J et al. (2014) Mycobacterium tuberculosis lipoprotein LprG binds lipoarabinomannan and determines its cell envelope localization to control phagolysosomal fusion. PLoS Pathog 10:e1004471
Svetlíková, Zuzana; Baráth, Peter; Jackson, Mary et al. (2014) Purification and characterization of the acyltransferase involved in biosynthesis of the major mycobacterial cell envelope glycolipid--monoacylated phosphatidylinositol dimannoside. Protein Expr Purif 100:33-9
Jackson, Mary (2014) The mycobacterial cell envelope-lipids. Cold Spring Harb Perspect Med 4:
Gaur, Rajiv L; Ren, Kangning; Blumenthal, Antje et al. (2014) LprG-mediated surface expression of lipoarabinomannan is essential for virulence of Mycobacterium tuberculosis. PLoS Pathog 10:e1004376
Albesa-Jove, David; Giganti, David; Jackson, Mary et al. (2014) Structure-function relationships of membrane-associated GT-B glycosyltransferases. Glycobiology 24:108-24
Grzegorzewicz, Anna E; Jackson, Mary (2013) Subfractionation and analysis of the cell envelope (lipo)polysaccharides of Mycobacterium tuberculosis. Methods Mol Biol 966:309-24
Jackson, Mary; McNeil, Michael R; Brennan, Patrick J (2013) Progress in targeting cell envelope biogenesis in Mycobacterium tuberculosis. Future Microbiol 8:855-75

Showing the most recent 10 out of 32 publications